Years before symptoms of Alzheimer's disease appear, two kinds of damaging proteins silently collect in the brain: amyloid beta and tau. Clumps of amyloid accumulate first, but tau is particularly noxious. Wherever tangles of the tau protein appear, brain tissue dies, triggering the confusion and memory loss that are hallmarks of Alzheimer's.
Now, researchers have found that the link between the two proteins may lie in the brain's immune cells that hem in clumps of amyloid. If the immune cells falter, amyloid clumps, or plaques, injure nearby neurons and create a toxic environment that accelerates the formation and spread of tau tangles, they report.
The findings, in mice and in people, are published in Nature Neuroscience. They suggest that reinforcing the activity of such immune cells - known as microglia - could slow or stop the proliferation of tau tangles, and potentially delay or prevent Alzheimer's dementia.
"I think we've found a potential link between amyloid and tau that people have been looking for for a long time," said senior author. "If you could break that link in people who have amyloid deposition but are still cognitively healthy, you might be able to stop disease progression before people develop problems with thinking and memory."
While the formation of amyloid plaques and tau tangles have been recognized as key steps in the development of Alzheimer's disease, researchers have struggled to pin down the relationship between the two. By themselves, amyloid plaques do not cause dementia. Many people over age 70 have some amyloid plaques in their brains, including some who are as mentally sharp as ever. But the presence of amyloid plaques seems to lead inexorably to the formation of tau tangles - the true villain of Alzheimer's - and, until now, it wasn't clear how amyloid drives tau pathology.
The authors suspected that microglia could be the link. A rare mutation in a gene called TREM2 leaves people with weak and ineffective microglia, and also increases their risk of developing Alzheimer's by twofold to fourfold.
As part of the study, the researchers used mice prone to developing amyloid plaques and modified in various ways their TREM2 genes to influence the activity of their microglia. The result was four groups of mice: two with fully functional microglia because they carried the common variant of either the human or mouse TREM2 gene, and two with impaired microglia that carried the high-risk human TREM2 variant or no copy of the TREM2 gene at all.
Then, the researchers seeded the mice's brains with small amounts of tau collected from Alzheimer's patients. The human tau protein triggered the tau in mice to coalesce into tangle-like structures around the amyloid plaques.
In mice with weakened microglia, more tau tangle-like structures formed near the amyloid plaques than in mice with functional microglia. Further experiments showed that microglia normally form a cap over amyloid plaques that limits their toxicity to nearby neurons. When the microglia fail to do their job, neurons sustain more damage, creating an environment that fosters the formation of tau tangle-like lesions.
Further, the researchers also showed that people with TREM2 mutations who died with Alzheimer's disease had more tau tangle-like structures near their amyloid plaques than people who died with Alzheimer's but did not carry the mutation.
"Even though we were looking at the brains of people at the end of the Alzheimer's process rather than the beginning, as in the mice, we saw the same kind of changes: more tau in the vicinity of amyloid plaques," the senior author said. "I'd speculate that in people with TREM2 mutations, tau accumulates and then spreads faster, and these patients develop problems with memory loss and thinking more quickly because they have more of those initial tau tangles."
The converse also may be true, the senior author said. Powering up microglia might slow the spread of tau tangles and forestall cognitive decline. Drugs that enhance the activity of microglia by activating TREM2 already are in the pipeline.
https://medicine.wustl.edu/news/alzheimers-missing-link-id-answering-what-tips-brains-decline/
https://www.nature.com/articles/s41593-019-0433-0
Latest News
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Mapping microbiome in metas…
By newseditor
Posted 22 Apr
Full-length mRNA packaged i…
By newseditor
Posted 22 Apr
Glucose-sensing mechanism t…
By newseditor
Posted 21 Apr
Other Top Stories
Fusion of macrophages form multinucleated giant cells to eliminate…
Read more
Diverse physiological role of natural killer cells in different tis…
Read more
Mechanism of inflammation induced memory impairment
Read more
Connecting cholesterol metabolism with inflammatory circuit
Read more
Body tightly controls inflammatory response to pathogens
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Neuronal activity rapidly r…
By newseditor
Posted 22 Apr
A perspective on muscle phe…
By newseditor
Posted 22 Apr
Foxp1 suppresses cortical a…
By newseditor
Posted 22 Apr
Single-cell long-read seque…
By newseditor
Posted 22 Apr
Unlocking potential: the ro…
By newseditor
Posted 22 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar